18-06-2020
Ugis Rigba / Shutterstock.com
The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
European Commission, COVID-19, vaccine, licensing, Heidi Chow, compulsory, WHO, World Health Assembly, resolution, strategy, patent pool
Ghana in licensing talks to manufacture AstraZeneca vaccine
27-04-2021
CPI receives £5m from UK govt for 'vaccine library'
04-03-2021
EU concludes COVID-19 vaccine talks with Pfizer
10-09-2020
EU reaches first COVID-19 vaccine deal
17-08-2020
Big pharma pushes back against WHO patent pool
04-06-2020
US rebukes IP wording in WHO’s pandemic resolution
20-05-2020
